Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)

China flag China · Delayed Price · Currency is CNY
56.37
+5.85 (11.58%)
Nov 20, 2024, 3:00 PM CST
50.64%
Market Cap 25.22B
Revenue (ttm) 3.20B
Net Income (ttm) 1.30B
Shares Out 450.00M
EPS (ttm) 2.88
PE Ratio 19.45
Forward PE 19.15
Dividend 0.50 (0.89%)
Ex-Dividend Date Sep 5, 2024
Volume 14,091,825
Open 51.25
Previous Close 50.52
Day's Range 51.25 - 57.19
52-Week Range 32.25 - 68.87
Beta 0.55
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Shanghai Allist Pharmaceuticals

Shanghai Allist Pharmaceuticals Co., Ltd. engages in the research and development of pharmaceutical products in China. It offers pharmaceuticals for the treatment of tumor and cancer diseases. The company was founded in 2004 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 1,044
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688578
Full Company Profile

Financial Performance

In 2023, Shanghai Allist Pharmaceuticals's revenue was 2.02 billion, an increase of 155.14% compared to the previous year's 791.00 million. Earnings were 644.17 million, an increase of 393.54%.

Financial Statements

News

There is no news available yet.